Frontiers in Medicine | |
SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment | |
article | |
Mathieu E. Rebeaud1  Florian Zores2  | |
[1] Faculty of Biology and Medicine, University of Lausanne;Groupe médical spécialisé | |
关键词: COVID-19; SARS-CoV-2; chloroquine; antiviral; 2019-nCoV; | |
DOI : 10.3389/fmed.2020.00184 | |
学科分类:社会科学、人文和艺术(综合) | |
来源: Frontiers | |
【 摘 要 】
In December 2019, a newly discovered SARS-CoV-2 virus emerged from China and propagated worldwide as a pandemic, becoming a major global public health issue. Different publications have discussed the possible efficacy of the antimalarial drug chloroquine (CQ) and its derivatives as a possible treatment against the disease, and, as the drug has often been recommended, we would like to shed a light on the previous experiments and trials conducted with CQ and its derivatives on several viruses, the outcomes being based on in vitro and in vivo results, and call for a well-designed clinical evaluation.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202108180001842ZK.pdf | 255KB | download |